These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
392 related items for PubMed ID: 32145968
1. Neonatal Intensive Care Unit-Level Patent Ductus Arteriosus Treatment Rates and Outcomes in Infants Born Extremely Preterm. Isayama T, Kusuda S, Reichman B, Lee SK, Lehtonen L, Norman M, Adams M, Bassler D, Helenius K, Hakansson S, Yang J, Jain A, Shah PS, International Network for Evaluating Outcomes of Neonates (iNeo) Investigators. J Pediatr; 2020 May; 220():34-39.e5. PubMed ID: 32145968 [Abstract] [Full Text] [Related]
2. Trends and Outcomes of Patent Ductus Arteriosus Treatment in Very Preterm Infants in Canada. Lokku A, Mirea L, Lee SK, Shah PS, Canadian Neonatal Network. Am J Perinatol; 2017 Apr; 34(5):441-450. PubMed ID: 27649293 [Abstract] [Full Text] [Related]
3. Patent ductus arteriosus management and outcomes in Japan and Canada: comparison of proactive and selective approaches. Isayama T, Mirea L, Mori R, Kusuda S, Fujimura M, Lee SK, Shah PS, Neonatal Research Network of Japan and the Canadian Neonatal Network. Am J Perinatol; 2015 Sep; 32(11):1087-94. PubMed ID: 25825965 [Abstract] [Full Text] [Related]
4. Covariation of Neonatal Intensive Care Unit-Level Patent Ductus Arteriosus Management and In-Neonatal Intensive Care Unit Outcomes Following Preterm Birth. Hagadorn JI, Bennett MV, Brownell EA, Payton KSE, Benitz WE, Lee HC. J Pediatr; 2018 Dec; 203():225-233.e1. PubMed ID: 30243544 [Abstract] [Full Text] [Related]
5. Variation and comparative effectiveness of patent ductus arteriosus pharmacotherapy in extremely low birth weight infants. ElHassan NO, Bird TM, King AJ, Ambadwar PB, Jaquiss RD, Kaiser JR, Robbins JM. J Neonatal Perinatal Med; 2014 Jan 01; 7(3):229-35. PubMed ID: 25322995 [Abstract] [Full Text] [Related]
6. Association Between Early Screening for Patent Ductus Arteriosus and In-Hospital Mortality Among Extremely Preterm Infants. Rozé JC, Cambonie G, Marchand-Martin L, Gournay V, Durrmeyer X, Durox M, Storme L, Porcher R, Ancel PY, Hemodynamic EPIPAGE 2 Study Group. JAMA; 2014 Jan 01; 313(24):2441-8. PubMed ID: 26103028 [Abstract] [Full Text] [Related]
7. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Ohlsson A, Walia R, Shah S. Cochrane Database Syst Rev; 2008 Jan 23; (1):CD003481. PubMed ID: 18254020 [Abstract] [Full Text] [Related]
10. Efficacy of pharmacologic closure of patent ductus arteriosus in small-for-gestational-age extremely preterm infants. Boghossian NS, Do BT, Bell EF, Dagle JM, Brumbaugh JE, Stoll BJ, Vohr BR, Das A, Shankaran S, Sanchez PJ, Wyckoff MH, Bethany Ball M, Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Early Hum Dev; 2017 Oct 23; 113():10-17. PubMed ID: 28697406 [Abstract] [Full Text] [Related]
11. The effect of hemodynamically significant patent ductus arteriosus on acute kidney injury and systemic hypertension in extremely low gestational age newborns. Velazquez DM, Reidy KJ, Sharma M, Kim M, Vega M, Havranek T. J Matern Fetal Neonatal Med; 2019 Oct 23; 32(19):3209-3214. PubMed ID: 29642731 [Abstract] [Full Text] [Related]
12. Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants. Ohlsson A, Walia R, Shah S. Cochrane Database Syst Rev; 2003 Oct 23; (2):CD003481. PubMed ID: 12804469 [Abstract] [Full Text] [Related]
13. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Ohlsson A, Walia R, Shah S. Cochrane Database Syst Rev; 2005 Oct 19; (4):CD003481. PubMed ID: 16235321 [Abstract] [Full Text] [Related]
14. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. Ohlsson A, Walia R, Shah SS. Cochrane Database Syst Rev; 2015 Feb 18; (2):CD003481. PubMed ID: 25692606 [Abstract] [Full Text] [Related]
15. Patent Ductus Arteriosus Treatment in Very Preterm Infants: A European Population-Based Cohort Study (EPICE) on Variation and Outcomes. Edstedt Bonamy AK, Gudmundsdottir A, Maier RF, Toome L, Zeitlin J, Bonet M, Fenton A, Hasselager AB, van Heijst A, Gortner L, Milligan D, Van Reempts P, Boyle EM, Norman M, collaborators from the EPICE Research Group. Neonatology; 2017 Feb 18; 111(4):367-375. PubMed ID: 28125815 [Abstract] [Full Text] [Related]
16. Mortality and extrauterine growth restriction of necrotizing enterocolitis in very preterm infants with heart disease: a multi-center cohort study. Lu P, Gong X, Gu X, Jiang S, Cao Y, Sun C, Du J, Lei X, Lee SK, Chinese Neonatal Network (CHNN). Eur J Pediatr; 2024 Aug 18; 183(8):3579-3588. PubMed ID: 38822834 [Abstract] [Full Text] [Related]
17. Recent Advances in the Treatment of Preterm Newborn Infants with Patent Ductus Arteriosus. Sallmon H, Koehne P, Hansmann G. Clin Perinatol; 2016 Mar 18; 43(1):113-29. PubMed ID: 26876125 [Abstract] [Full Text] [Related]
18. [Ibuprofen--a new application for pharmacological closure of patent ductus arteriosus in preterm infants. Preliminary report]. Adamska E. Med Wieku Rozwoj; 2000 Mar 18; 4(2 Suppl 3):65-71. PubMed ID: 11328971 [Abstract] [Full Text] [Related]
19. Enteral feeding during indomethacin treatment for patent ductus arteriosus: association with gastrointestinal outcomes. Louis D, Torgalkar R, Shah J, Shah PS, Jain A. J Perinatol; 2016 Jul 18; 36(7):544-8. PubMed ID: 26914015 [Abstract] [Full Text] [Related]
20. Prophylactic Indomethacin Compared with Delayed Conservative Management of the Patent Ductus Arteriosus in Extremely Preterm Infants: Effects on Neonatal Outcomes. Liebowitz M, Clyman RI. J Pediatr; 2017 Aug 18; 187():119-126.e1. PubMed ID: 28396025 [Abstract] [Full Text] [Related] Page: [Next] [New Search]